Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

The Pharmaceutical Journal report on outsourcing of hospital pharmacy services cited in parliamentary debate

MPs in the House of Commons were told of the issue of outsourcing pharmacy services, after a report highlighting the issue was published in The Pharmaceutical Journal.

Houses of Parliament

Source: Shutterstock.com

MPs at the House of Commons were read statistics, reported in The Pharmaceutical Journal, showing that 34% of trusts had outsourced their pharmacy service to a commercial firm and 16% have created wholly owned subsidiaries

A news story in The Pharmaceutical Journal news story has been cited in a parliamentary debate on Hospital Improvement Plans: VAT Rules.

Karin Smyth, Labour Party MP for Bristol South, told the House of Commons on 9 January 2020 that “just this week, The Pharmaceutical Journal reported that 34% of trusts had outsourced their pharmacy service to a commercial firm and 16% have created wholly owned subsidiaries”.

Smyth noted that the practice of outsourcing pharmacy services was “widespread”, but added that similar schemes proposed at Bradford Teaching Hospitals NHS Foundation Trust and the Frimley Health NHS Trust “have been vigorously opposed, particularly by Unison, and it appears that both proposed schemes have been stopped” — which she described as “good news for thousands of low-paid staff who wish to remain NHS employees.”

Smyth added that the establishment of subsidiaries “might make sense in the short term for individual trusts, but it makes no sense for the wider health economy or the whole NHS,” and claimed that “the practice is not a strategic, collaborative or positive solution to the problems that trusts face, and it is not about better employment”.

In response, Edward Argar, the minister of state for health, told MP that plans were already being made to review the VAT rules, adding that “while there can be VAT advantages of forming wholly owned subsidiary companies, we are clear that they cannot and should not be set up for the purposes of VAT avoidance, and we wrote to all provider trusts in September 2017 to remind them of their clear tax responsibilities”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207557

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.